<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3219">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04509986</url>
  </required_header>
  <id_info>
    <org_study_id>GS-CSWeek.20200713</org_study_id>
    <nct_id>NCT04509986</nct_id>
  </id_info>
  <brief_title>GlobalSurg-CovidSurg Week</brief_title>
  <official_title>GlobalSurg-CovidSurg Week: Determining the Optimal Timing for Surgery Following SARS-CoV-2 Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute for Health Research (NIHR) Global Health Research Unit Grant (NIHR 16.136.79)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Association of Coloproctology of Great Britain and Ireland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bowel &amp; Cancer Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Association of Upper Gastrointestinal Surgeons; British Association of Surgical Oncology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bowel Disease Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>British Gynaecological Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>European Society of Coloproctology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NIHR Academy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sarcoma UK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vascular Society for Great Britain and Ireland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yorkshire Cancer Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Birmingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study to determine the optimal timing for surgery following SARS-CoV-2
      infection and assess key global surgery indicators.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Prospective, observational international cohort study.

        -  Any hospital worldwide can participate (including hospitals that have not admitted
           SARS-CoV-2 infected patients).

        -  All patients undergoing a surgical procedure in an operating theatre will be included.
           All consecutive eligible patients should be included.

        -  7-day data collection period, with follow-up at 30 days after surgery for each patient.
           However, no changes should be made to normal patient care/ follow-up pathways

        -  Primary outcome is 30-day mortality.

        -  All collaborators will be included as PubMed-citable co-authors on resulting
           publications.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative mortality</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Mortality at 30 days after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>In-patient mortality</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Mortality while the patient is admitted to hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pulmonary complications</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>30-day postoperative pulmonary complications (pneumonia [CDC definition], ARDS, unexpected ventilation)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative venous thromboembolism</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>30-day venous thromboembolism (deep vein thrombosis/ pulmonary embolism)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative complications</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>30-day Clavien-Dindo grade</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Surgery</condition>
  <condition>Covid19</condition>
  <condition>Post-Op Complication</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients undergoing surgery done in an operating theatre by a surgeon.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria

          -  Any operation (elective or emergency) done in an operating theatre by a surgeon.

          -  All surgical specialties including: acute care surgery, breast surgery, cardiac
             surgery, colorectal surgery, general surgery, gynaecology, hepatobiliary surgery,
             neurosurgery, obstetrics, oesophagogastric surgery, ophthalmology, oral and
             maxillofacial surgery, orthopaedics, otolaryngology, paediatric surgery, plastic
             surgery, thoracic surgery, transplant surgery, trauma surgery, urology, vascular
             surgery.

          -  Day case surgery and inpatient surgery included.

          -  Any SARS-CoV-2 status (positive at any time, negative, not tested).

          -  All ages including children and adults.

        Exclusion criteria:

        Minor procedures (full list will be available in the protocol).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Aneel Bhangu, PhD</last_name>
    <phone>+44 (0) 121 3718121</phone>
    <email>aneel.bhangu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dmitri Nepogodiev, Master</last_name>
    <phone>+44 (0) 121 3718121</phone>
    <email>D.Nepogodiev@bham.ac.uk</email>
  </overall_contact_backup>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 11, 2020</study_first_submitted>
  <study_first_submitted_qc>August 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 12, 2020</study_first_posted>
  <last_update_submitted>August 11, 2020</last_update_submitted>
  <last_update_submitted_qc>August 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

